V114i NKT cells have been implicated in the regulation of immune responses associated with a broad range of diseases, including autoimmunity, infectious diseases and cancer. Their regulatory functions are thought to be mediated by their action on other cells of the immune system, yet the nature of the putative interactions among these cells in vivo during the immune response is totally unknown. V114i NKT cells behavior in situ represents a new area of investigation that has been vastly ignored because of the lack of tools necessary to uniquely track these cells. We propose to generate a new transgenic mouse model that will allow for the visualization of labeled-V114i NKT cells among unlabeled """"""""conventional"""""""" T cells. This situation will recapitulate as closely as possible the """"""""normal"""""""" repertoire of wild-type animals and will permit the study of the in situ behavior of V114i NKT cells in resting animals.

Public Health Relevance

Natural Killer T cells (NKT cells) play an important role in regulating a variety of immune responses. Several major advances have been made in the recent years regarding how these cells develop, recognize their antigens and influence immune responses. Yet, the localization of this lymphocyte population in tissues and its migratory behavior remains unexplored. This is largely due to the lack of reagents and models to unambiguously identify this cell population directly in vivo. The proposed studies aim at producing an animal model that will allow for the visualization of the NKT cell population directly in vivo. An understanding of NKT cell localization and trafficking in tissues could potentially be exploited for therapeutic usage to improve human health.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21AI076463-02
Application #
7624640
Study Section
Innate Immunity and Inflammation Study Section (III)
Program Officer
Miller, Lara R
Project Start
2008-07-01
Project End
2011-06-30
Budget Start
2009-07-01
Budget End
2011-06-30
Support Year
2
Fiscal Year
2009
Total Cost
$192,636
Indirect Cost
Name
University of Colorado Denver
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Young, Mary H; U'Ren, Lance; Huang, Shouxiong et al. (2013) MAIT cell recognition of MR1 on bacterially infected and uninfected cells. PLoS One 8:e53789
Yin, Lei; Scott-Browne, James; Kappler, John W et al. (2012) T cells and their eons-old obsession with MHC. Immunol Rev 250:49-60
Mallevaey, Thierry; Clarke, Andrew J; Scott-Browne, James P et al. (2011) A molecular basis for NKT cell recognition of CD1d-self-antigen. Immunity 34:315-26
Wun, Kwok S; Cameron, Garth; Patel, Onisha et al. (2011) A molecular basis for the exquisite CD1d-restricted antigen specificity and functional responses of natural killer T cells. Immunity 34:327-39
Pellicci, Daniel G; Clarke, Andrew J; Patel, Onisha et al. (2011) Recognition of ?-linked self glycolipids mediated by natural killer T cell antigen receptors. Nat Immunol 12:827-33
Scott-Browne, James P; Crawford, Frances; Young, Mary H et al. (2011) Evolutionarily conserved features contribute to ?? T cell receptor specificity. Immunity 35:526-35
Young, Mary H; Gapin, Laurent (2011) Group 1 CD1-restricted T cells take center stage. Eur J Immunol 41:592-4
Scott-Browne, James P; White, Janice; Kappler, John W et al. (2009) Germline-encoded amino acids in the alphabeta T-cell receptor control thymic selection. Nature 458:1043-6
Gapin, Laurent (2009) Where do MAIT cells fit in the family of unconventional T cells? PLoS Biol 7:e70
Mallevaey, Thierry; Scott-Browne, James P; Matsuda, Jennifer L et al. (2009) T cell receptor CDR2 beta and CDR3 beta loops collaborate functionally to shape the iNKT cell repertoire. Immunity 31:60-71

Showing the most recent 10 out of 11 publications